Skip to main content
. Author manuscript; available in PMC: 2013 Jul 3.
Published in final edited form as: J Am Geriatr Soc. 2007 Jun;55(6):900–906. doi: 10.1111/j.1532-5415.2007.01187.x

Table 2.

Unadjusted Characteristics and Domain-Specific Logistic Regression Models of the Likelihood of Receiving a Prescription for a Prosthesis (n = 629)

Characteristic Received Prescription % Odds Ratio (95% Confidence Interval)
Age
  <76 31.2 4.56 (1.79–11.60)
  76–85 14.9 2.09 (0.81–5.44)
  ≥86 (reference) 7.0 1.0
Sex
  Male 26.6 2.15 (0.69–6.67)
  Female (reference) 15.4 1.0
Marital status
  Married 25.4 0.92 (0.75–1.11)
  Not married (reference) 27.4 1.0
Living circumstance before hospitalization
  Extended care 16.3 0.65 (0.46–0.93)
  Hospital 29.6 1.35 (0.81–2.28)
  Home (reference) 27.7 1.0
Amputation level
  Transtibial 35.6 3.49 (2.77–4.40)§
  Transfemoral (reference) 19.5 1.0
Etiology
  Chronic osteomyelitis 31.2 1.03 (0.70–1.51)
  Device infection 27.8 1.14 (0.84–1.55)
  Diabetes mellitus type I 29.8 0.94 (0.73–1.21)
  Diabetes mellitus type II 28.5 1.10 (0.88–1.38)
  Local significant infection 25.8 0.86 (0.67–1.11)
  Previous amputation complication* 30.5 1.10 (0.78–1.53)
  Problems with peripheral circulation 25.2 0.73 (0.55–0.98)
  Skin breakdown 26.2 0.89 (0.72–1.10)
  Systemic sepsis 17.6 0.50 (0.35–0.71)
  Trauma 33.7 1.20 (0.92–1.58)
Elixhauser comorbidities‖
  Acquired immunodeficiency syndrome 23.5 0.56 (0.17–1.82)
  Alcohol abuse 40.8 1.61 (1.07–2.44)
  Arrhythmias 19.9 0.95 (0.71–1.28)
  Chronic blood loss anemias 11.1 0.41 (0.16–1.09)
  Chronic pulmonary diseases 22.4 0.91 (0.70–1.18)
  Coagulopathy 18.3 0.67 (0.39–1.15)
  Congestive heart failure 20.8 0.67 (0.52–0.87)
  Deficiency anemias 26.6 1.13 (0.88–1.46)
  Depression 31.8 1.17 (0.83–1.63)
  Diabetes mellitus 26.2 0.94 (0.75–1.18)
  Diabetes mellitus with chronic complication 29.1 0.99 (0.79–1.22)
  Drug abuse 46.3 1.64 (0.89–3.01)
  Fluid and electrolyte disturbances 21.5 0.81 (0.62–1.06)
  Hypertension 27.3 1.12 (0.91–1.38)
  Hypertension with complication 38.5 1.88 (0.56–6.31)
  Hypothyroidism 28.1 1.28 (0.77–2.15)
  Liver disease 33.3 1.08 (0.65–1.80)
  Lymphoma 11.1 0.61 (0.07–5.46)
  Metastatic cancer 9.4 0.29 (0.08–0.99)
  Other neurological disorders 8.3 0.28 (0.12–0.67)
  Paralysis 5.4 0.16 (0.06–0.41)
  Peptic ulcer disease with bleeding 28.6 0.80 (0.36–1.74)
  Peripheral vascular disease 24.9 0.84 (0.67–1.05)
  Psychoses 21.3 0.61 (0.40–0.93)
  Pulmonary circulation diseases 11.8 0.40 (0.09–1.89)
  Renal failure 22.4 0.75 (0.57–0.99)
  Rheumatoid arthritis 18.8 0.61 (0.24–1.57)
  Solid tumor without metastasis 26.5 1.18 (0.80–1.73)
  Valvular diseases 23.4 1.15 (0.70–1.88)
  Weight loss 17.4 0.67 (0.39–1.15)
Medical acuity
  Active pulmonary pathology 17.2 0.91 (0.32–2.56)
  Acute central nervous system 15.4 0.59 (0.39–0.90)
  Mental health issues or substance abuse 18.8 0.71 (0.28–1.81)
  Ongoing active cardiac pathology 22.8 0.88 (0.64–1.20)
  Ongoing wound problems 24.8 0.84 (0.55–1.28)
  Serious nutritional compromise 10.7 0.51 (0.27–0.94)
  Severe renal disease 18.8 0.54 (0.37–0.79)
Initial FIM score
  Cognitive
    5–13 (reference) 12.3 1.0
    14–21 21.1 1.30 (0.74–2.30)
    22–28 27.6 1.63 (0.99–2.70)
    29–35 37.4 1.67 (1.03–2.70)
  Motor
    13–32 (reference) 16.8 1.0
    33–52 34.4 1.82 (1.34–2.47)
    53–72 45.6 2.62 (1.88–3.65)§
    73–91 42.6 2.18 (1.36–3.50)

Note: Etiologies, comorbidities, medical acuity, and initial functional status were studied in separate domain-specific models controlling for age, sex, marital status, living circumstance before hospitalization, and amputation level. N = 2,374 for sociodemographics, etiologies, comorbidities, and medical acuity regression models because one patient was missing living circumstance before hospitalization. N = 1,722 for initial functional status because the Functional Independence Measure (FIM) was measured only for veterans with amputations who were seen in rehabilitation services.

*

Amputations that likely occurred more than a year earlier.

P < .05; .01; §.001.

Congenital deformity, lower extremity cancer, and obesity were not included in analyses because of low prevalence.